SMid Biotech Analyst Cheng holds a conference call with Kyverna’a Scientific Advisor Schett on June 17 at 12 pm hosted by JPMorgan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- After Kyverna data, Oppenheimer says Cartesian ‘can exploit’ CAR-T’s ‘baggage’
- Kyverna: KYV-101 demonstrates ‘promising’ outcomes across multiple indications
- Kyverna, Cabaletta selloffs an overreaction, says Wells Fargo
- Kyverna weakness after EULAR update ‘an overreaction,’ says JPMorgan
- Kyverna Therapeutics Inc trading resumes